Consolidated Financial Results
for the Second Quarter
of the Fiscal Year Ending Mar. 31, 2022
TSE 1st Section : Ticker 7780
Menicon Co., Ltd.
November 12, 2021
Copyright: Menicon Co., Ltd. All rights reserved.
Table of Contents
I. Summary of Consolidated Financial Results for FY2021 2Q
Ⅱ. Forecast of Consolidated Financial Results
for FY2021
Ⅲ. Growth Strategies
Copyright: Menicon Co., Ltd. All rights reserved.
I. Summary of Consolidated Financial Results
for FY2021 2Q
Copyright: Menicon Co., Ltd. All rights reserved.
Key Factors
- Financial Results for FY2021 2Q (Six Months Ended)
Net sales | : YoY +JPY 6.87 bn / +16.6% (Increase in Sales) |
- With the addition of sales bases in China (Itabashi Trading Group), the overseas sales growth
- Overseas sales: JPY 6.79 bn → JPY 11.70 bn (+72.4%)
- Overseas sales ratio: 16.4% → 24.2%
Gross profit : YoY +JPY 3.69 bn / +16.7% (Increase in Profit)
Cost to sales ratio: 46.7% → 46.7%
Operating profit: YoY +JPY 0.56 bn / +12.5% (Increase in Profit)
Operating profit ratio: 10.8% → 10.5%
3
Copyright: Menicon Co., Ltd. All rights reserved.
Key Factors
- Vision care sales ...
Japan : Increase in average spend per customer due to an increase in MELS Plan members of Daily disposable contact lenses
Overseas: Increase in sales volume of Orthokeratology lenses and Lens care products mainly in Asia (China)
- Healthcare and life care sales ...
Addition of Food business (Itabashi Trading became a wholly owned subsidiary in January 2021)
JPY bn | Net sales (2Q) | YoY | |||||||
Sales Growth : YoY 16.6% | |||||||||
60 | +25.0% | ||||||||
483 | |||||||||
428 | 415 | +16.6% | |||||||
381 | 400 | ||||||||
40 | 330 | 349 | +15.0% | ||||||
+9.3% | ||
20 | +5.0% | +6.8% |
+5.7% | +5.0% | |
3.0% | ||||||
0 | － | |||||
FY2015 2Q | FY2016 2Q | FY2017 2Q | FY2018 2Q | FY2019 2Q | FY2020 2Q | FY2021 2Q |
MELS Plan | Product sales* | Helthcare and life care | YoY | |||
－5.0%
4
*Product sales: Sales of contact lenses and Lens care products
Copyright: Menicon Co., Ltd. All rights reserved.
This is an excerpt of the original content. To continue reading it, access the original document here.